This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Nov;56(5):761-2; discussion 763.

doi: 10.1016/j.eururo.2009.07.048. Epub 2009 Aug 4.

Prostate-specific antigen dynamics and prostate cancer diagnosis

Riccardo Bartoletti

PMID: 19665286
DOI: 10.1016/j.eururo.2009.07.048

Editorial

Prostate-specific antigen dynamics and prostate cancer diagnosis

Riccardo Bartoletti. Eur Urol. 2009 Nov.

. 2009 Nov;56(5):761-2; discussion 763.

doi: 10.1016/j.eururo.2009.07.048. Epub 2009 Aug 4.

Author

Riccardo Bartoletti

PMID: 19665286
DOI: 10.1016/j.eururo.2009.07.048

No abstract available

PubMed Disclaimer

Comment on

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort.
Vickers AJ, Wolters T, Savage CJ, Cronin AM, O'Brien MF, Pettersson K, Roobol MJ, Aus G, Scardino PT, Hugosson J, Schröder FH, Lilja H. Vickers AJ, et al. Eur Urol. 2009 Nov;56(5):753-60. doi: 10.1016/j.eururo.2009.07.047. Epub 2009 Aug 7. Eur Urol. 2009. PMID: 19682790 Free PMC article.

Similar articles

Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
Carroll PR, Whitson JM, Cooperberg MR. Carroll PR, et al. J Clin Oncol. 2011 Feb 1;29(4):345-7. doi: 10.1200/JCO.2010.32.5308. Epub 2010 Dec 28. J Clin Oncol. 2011. PMID: 21189396 No abstract available.
Can we accurately identify men with low risk prostate cancer?
Neal DE. Neal DE. J Urol. 2008 Oct;180(4):1217-8. doi: 10.1016/j.juro.2008.07.086. Epub 2008 Aug 15. J Urol. 2008. PMID: 18707718 No abstract available.
Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in Prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥ 100).
Roobol MJ, Schröder FH, van Leenders GL, Hessels D, van den Bergh RC, Wolters T, van Leeuwen PJ. Roobol MJ, et al. Eur Urol. 2010 Dec;58(6):893-9. doi: 10.1016/j.eururo.2010.09.030. Epub 2010 Sep 26. Eur Urol. 2010. PMID: 20933321 Clinical Trial.
Prostate specific antigen: an updated review.
So A, Goldenberg L, Gleave ME. So A, et al. Can J Urol. 2003 Dec;10(6):2040-50. Can J Urol. 2003. PMID: 14704108 Review.
Prognostic value of serum markers for prostate cancer.
Stenman UH, Abrahamsson PA, Aus G, Lilja H, Bangma C, Hamdy FC, Boccon-Gibod L, Ekman P. Stenman UH, et al. Scand J Urol Nephrol Suppl. 2005 May;(216):64-81. doi: 10.1080/03008880510030941. Scand J Urol Nephrol Suppl. 2005. PMID: 16019759 Review.

See all similar articles

Cited by

[Problems, objective, and substance of early detection of prostate cancer].
Börgermann C, Loertzer H, Hammerer P, Fornara P, Graefen M, Rübben H. Börgermann C, et al. Urologe A. 2010 Feb;49(2):181-9. doi: 10.1007/s00120-010-2234-7. Urologe A. 2010. PMID: 20180057 German.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information